| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |